About Us

Our Journey ofHealthcare Innovation

Leading the way in pharmaceutical excellence as the fastest-growing Indo-American company, delivering breakthrough solutions across six nations.

Our Story

Leading the Future of Global Healthcare

Founded with a vision to revolutionize global healthcare, Hendrix Pharmaceuticals stands as a testament to Indo-American collaboration and excellence. In a remarkably short time, we've emerged as the fastest-growing pharmaceutical company spanning seven nations, driven by our commitment to innovation and quality.

Our journey is marked by a relentless pursuit of excellence, evidenced by our WHO-GMP and FDA approvals, ISO 9001-2015 standards, and International Accredited Forum Registration (IAF). These achievements reflect our dedication to maintaining the highest standards in pharmaceutical manufacturing and research.

7 Countries
Global Network
Millions Served
Healthcare Impact

Our Journey

2023
Foundation
Established as an Indo-American pharmaceutical venture
2023
Global Expansion
Rapidly expanded presence across seven nations
2023-24
Certifications
Achieved WHO-GMP, FDA approvals & ISO certification

International Standards & Certifications

Our commitment to excellence reflected in global recognitions

WHO-GMP

World Health Organization Good Manufacturing Practice

FDA Approved

Food and Drug Administration Certification

ISO 9001-2015

International Organization for Standardization

IAF Registration

International Accreditation Forum

Global Presence

Operating across seven strategic international markets

India

South Asia

United Kingdom

Europe

United States

North America

Canada

North America

GCC Countries

Middle East

Africa

Continental

Australia

Oceania

Our Leadership

Leadership Team

Dr. Peter

Advanced Healthcare Pioneer

Leading Cynord Cancer Centre with advanced CAR-T cell therapy and bone marrow transplant (BMT) units.

Founder & CEO

Dr. Peter

A distinguished serial entrepreneur in the global healthcare industry, leading Hendrix Medical Group of Companies (HMGC) and associated with Cynord Cancer Centre, renowned for its advanced CAR-T cell therapy and bone marrow transplant (BMT) units.

Education

Master of Science in Clinical Service Operations

Harvard Medical School, Boston, USA

Professional Journey

Started as Drug Safety Associate at Vigilare Biopharma (2017)

Medical Officer for Phase 3 trials on tuberculosis

Led Covaxin Emergency Use Authorization with ICMR

Successfully managed TB trials with 1,200 volunteers

Expertise

Clinical Trials
Human trials expertise
Regulatory Affairs
USFDA, LATAM, EMA, ROW
Munawar Khan

Business Analytics Expert

Utilizing cutting-edge data-driven strategies for healthcare solutions.

Managing Director - India

Munawar Khan

Combines deep analytical expertise with visionary leadership to drive innovation and operational excellence. His academic foundation in business analytics empowers data-driven strategies for high-quality healthcare solutions.

Education

Master's in Business Analytics

University of East London

Focus Areas

Data-driven strategies

Building strong partnerships

Fostering growth

High-quality healthcare solutions

MS Sharjeel

Healthcare Excellence

Delivering amazing work with major healthcare and pharmaceuticals in the United States.

Managing Director - USA

Ms Sharjeel

A dynamic leader with a Master's degree in Business Analytics from the University of North Texas, bringing a unique blend of analytical expertise and strategic vision to drive sustainable growth and innovation.

Education

Master's in Business Analytics

University of North Texas

Key Focus Areas

Sustainable growth

Innovation

High-quality healthcare solutions

Excellence in delivery

Areas of Impact

US Healthcare
Major partnerships
Analytics
Business expertise

Join Our Vision

Be part of our journey to transform global healthcare through innovation and excellence.